D. E. Shaw & Co., Inc. Jazz Pharmaceuticals PLC Put Options Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $3.19 Million - $3.96 Million	-24,620 Reduced 71.11%	10,000 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $1.2 Million - $1.46 Million	10,000 Added 40.62%	34,620 $4.41 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $1.88 Million - $2.7 Million	14,620 Added 146.2%	24,620 $3.21 Million
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $1.68 Million - $1.94 Million	-11,200 Reduced 52.83%	10,000 $1.64 Million
Q3 2020 Nov 16, 2020	SELL	$105.46 - $144.13 $1.16 Million - $1.59 Million	-11,000 Reduced 34.16%	21,200 $3.02 Million
Q2 2020 Aug 14, 2020	SELL	$95.68 - $121.88 $1.25 Million - $1.6 Million	-13,100 Reduced 28.92%	32,200 $3.55 Million
Q1 2020 May 15, 2020	BUY	$87.74 - $152.74 $1.01 Million - $1.76 Million	11,500 Added 34.02%	45,300 $4.52 Million
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $3.98 Million - $5.2 Million	33,800 New	33,800 $5.05 Million

514

57.6M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.56B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.